CVS Health on Wednesday reported that it's been hit hard by higher medical costs. It led the company to slash its full-year ...
For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...
GSK wants to present Blenrep to regulatory bodies sooner. The UK pharma will submit Blenrep in second-line multiple myeloma ...
Neurocine Biosciences won FDA approval on Tuesday for a new formulation that may help Ingrezza go down in a more delightful ...
Senators questioned UnitedHealth Group CEO Andrew Witty for more than two hours on Tuesday over the February cyberattack that paralyzed the US healthcare industry for months and bled some providers ...
Sen. Maggie Hassan (D-NH) is pressuring GSK to put a commonly used pediatric inhaler back on the market after the company stopped producing it in late 2023 in favor of an authorized generic version.
The new round of letters targets 20 products and follows a push by the FTC last year to go after patents on asthma ...
GSK’s vaccines portfolio is front and center as it kicks off 2024. The UK pharma made £7.36 billion ($9.18 billion) in ...
Pacific Biosciences is letting go of 190 employees, according to the company, as part of cost-cutting measures after ...
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Piction Health, which ...
Real Chemistry plans to harness the “Wild West” of GLP-1 social media and reams of competitive data in the drug category with ...
Enlaza Therapeutics raised $100 million to develop permanently binding antibody-drug conjugates for cancer with a goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results